Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mayo Clinic
To conduct a cluster-randomized practical trial to evaluate the impact of our decision aid (Diabetes Medication Choice Cards) versus usual care as strategies to translate CER into practice among patients with poorly controlled diabetes in need of drug intensification (Hemoglobin Alc (HbA1c) \> 7.3%). Patient outcomes including reaching glycemic control target (HbA1c less than or equal to 7.3%), medication choice and adherence, satisfaction and knowledge. From the physician perspective, we will be measuring physician adoption and satisfaction with the decision aid.
To identify, describe, and explain factors that promote or inhibit the uptake of complex interventions such as decision aids in practices participating in the trial.
To conduct an exploratory analysis of the ability of patients to adhere to the medications chosen while exploring the factors that enable or hinder the patients' ability to incorporate these medications into their routine.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
18 years of age and older
Have a diagnosis of Type 2 diabetes mellitus and on diabetes medication
Have a diagnosis of Type 2 diabetes mellitus for 1 year or more if not currently on diabetes medication
Recognize their primary care provider as their main diabetes care provider
Use 0, 1, 2, or 3 oral hypoglycemic agents
Have a recent HbA1c measure (within 12 months) of greater than 7.3, with priority to patients with rising HbA1c levels.
You may not be if
Not available for follow-up for 12 months after study visit.
Unable to read and speak English.
Has major barriers to providing written informed consent.